- Unlock Trading Signals *EVERYDAY*, Follow Smart Money & Early Alpha in our Crypto Discord - https://www.patreon.com/jacobcryptobury/membership
3 extracted signals · 3 resolved · 0 still active
Jacob Crypto BuryIndependent analyst profile- Source published
- 16 Aug 2025, 19:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analyst assesses the cryptocurrency market and identifies four potential investment opportunities during a market correction in an uptrend. The first is Arbitrum (ARB), currently priced at $0.47, after hitting $0.57 a few days prior. The analyst considers this a good discount for dollar-cost averaging. Next, Injective is mentioned which he says is $14.26, slightly down from $15.25 the previous day, and trading around these values is considered a good entry point. Also is discussed Aave as a very good trading coin at this correction stage and is trading at 296, the analyst estimates it can hit 400 or even 500. Finally, analyst is going short in XRP, even without mentioning current prices he estimates the correction to start. Bitcoin Hyper is discussed, a presale, layer two scaling for bitcoin.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Jacob Crypto Bury
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.


